Interventional Oncology Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

Description

Persistence Market Research has recently published an extensive report on the global Interventional Oncology Market. This report offers a comprehensive analysis of the key market dynamics, including drivers, trends, opportunities, and challenges, providing deep insights into the market structure.

Key Insights:

Interventional Oncology Market Size (2024E): USD 2.1 Bn
Projected Market Value (2031F): USD 3.5 Bn
Global Market Growth Rate (CAGR 2024 to 2031): 8.1%

Interventional Oncology Market - Report Scope:

The Interventional Oncology Market involves the application of minimally invasive procedures for cancer treatment, utilizing advanced technologies such as radiofrequency ablation, cryoablation, and microwave ablation. These techniques aim to reduce patient discomfort and recovery time while providing effective tumor targeting, driving demand for such treatments in hospitals, clinics, and homecare settings. The market growth is propelled by the rising prevalence of cancer, technological advancements in imaging, and a growing focus on patient-centric care. Innovations in sedation, pain management, and monitoring technologies further support market expansion, enhancing the overall procedural experience for patients.

Market Growth Drivers:

The global Interventional Oncology Market is primarily driven by the increasing prevalence of cancer and the growing adoption of minimally invasive treatments. Technological advancements in imaging and interventional devices are enhancing procedural accuracy and safety, contributing to better patient outcomes. Furthermore, the demand for targeted cancer therapies is on the rise as patients and healthcare providers increasingly prefer less invasive treatment options that offer quicker recovery times and reduced complications. Innovations in device technology and the growing emphasis on personalized cancer treatments are also fueling market growth, with investments in research and development advancing new techniques.

Market Restraints:

Despite its promising growth, the Interventional Oncology Market faces challenges such as limited accessibility to advanced treatments in low and middle-income countries. Inadequate healthcare infrastructure, a shortage of specialized professionals, and the high cost of state-of-the-art equipment restrict the adoption of these treatments in resource-constrained regions. Moreover, disparities in access to the latest interventional oncology technologies hinder patient outcomes, particularly in developing nations. Addressing these barriers will require focused efforts to improve healthcare infrastructure, training, and the availability of advanced cancer care worldwide.

Market Opportunities:

Significant opportunities exist within the Interventional Oncology Market, especially with the increasing demand for personalized and home-based healthcare solutions. Innovations in imaging tools, including MRI and CT scans, are enhancing the precision of tumor targeting, creating opportunities for further market growth. The expansion of e-commerce platforms and direct-to-consumer sales channels is also providing easier access to these technologies, particularly in remote areas. Additionally, collaborations with healthcare providers and wellness centers are promoting the adoption of interventional oncology devices, further driving market expansion.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the Interventional Oncology Market globally?
Which product types, such as ablation devices, are expanding the most in the market?
How are advancements in imaging technologies and patient monitoring influencing the competitive landscape of the Interventional Oncology Market?
Who are the key players in the Interventional Oncology Market, and what strategies are they using to maintain their competitive edge?
What are the emerging trends and future prospects in the global Interventional Oncology Market?

Competitive Intelligence and Business Strategy:

Leading players in the global Interventional Oncology Market are focusing on innovation, strategic collaborations, and research and development to maintain a competitive edge. Companies are investing in the development of advanced ablation devices and exploring new product formats to meet evolving patient needs. Collaborations with hospitals, clinics, and healthcare providers help facilitate the adoption of these technologies, while marketing strategies emphasize consumer education and high-quality products. These efforts, combined with a focus on improving patient outcomes and minimizing recovery times, are contributing to sustained growth in the Interventional Oncology Market.

Key Market Players

Profound Medical
Medtronic Plc.
Hologic, Inc.
Boston Scientific Corporation
AngioDynamics
Terumo Corporation
Teleflex Incorporated
Alpinion Medical Systems Co. Ltd.
Siemens Healthineers
Merit Medical

Interventional Oncology Industry Segmentation

By Product

Radiation Therapy Devices
Ablation Devices
Embolization Devices

By Cancer Type

Lung Cancer
Liver Cancer
Kidney Cancer
Others

By End User

Hospitals
Specialty Clinics
Ambulatory Surgical Centre

By Region

North America
Europe
Asia Pacific
The Middle East and Africa
Latin America

Product Code: PMRREP34749

1. Executive Summary

1.1. Global Interventional Oncology Market Snapshot, 2024-2031
1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
2.3. Macro-Economic Factors
- 2.3.1. Global Sectorial Outlook
- 2.3.2. Global GDP Growth Outlook
- 2.3.3. Global Healthcare Spending Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

3.1. Regulatory Landscape
3.2. Product Adoption Analysis
3.3. Value Chain Analysis
3.4. Key Deals and Mergers
3.5. PESTLE Analysis
3.6. Porter's Five Force Analysis

4. Global Interventional Oncology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

4.1. Key Highlights
- 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
- 4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Bn) Analysis and Forecast
- 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2023
- 4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2023-2031
4.3. Global Interventional Oncology Market Outlook: Product
- 4.3.1. Introduction / Key Findings
- 4.3.2. Historical Market Size (US$ Bn) Analysis, By Product, 2019-2023
- 4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
  - 4.3.3.1. Radiation Therapy Devices
  - 4.3.3.2. Ablation Devices
    - 4.3.3.2.1. Microwave ablation
    - 4.3.3.2.2. Radiofrequency ablation
    - 4.3.3.2.3. Cryoablation
    - 4.3.3.2.4. Others
  - 4.3.3.3. Embolization Devices
    - 4.3.3.3.1. Microcatheters
    - 4.3.3.3.2. Guidewires
4.4. Market Attractiveness Analysis: Product
4.5. Global Interventional Oncology Market Outlook: Cancer Type
- 4.5.1. Introduction / Key Findings
- 4.5.2. Historical Market Size (US$ Bn) Analysis, By Cancer Type, 2019-2023
- 4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2024-2031
  - 4.5.3.1. Lung Cancer
  - 4.5.3.2. Liver Cancer
  - 4.5.3.3. Kidney Cancer
  - 4.5.3.4. Others
4.6. Market Attractiveness Analysis: Cancer Type
4.7. Global Interventional Oncology Market Outlook: End User
- 4.7.1. Introduction / Key Findings
- 4.7.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2023
- 4.7.3. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
  - 4.7.3.1. Hospitals
  - 4.7.3.2. Specialty Clinics
  - 4.7.3.3. Ambulatory Surgical Center
  - 4.7.3.4. Others
4.8. Market Attractiveness Analysis: End User

5. Global Interventional Oncology Market Outlook: Region

5.1. Key Highlights
5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2023
5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2024-2031
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. East Asia
- 5.3.4. South Asia and Oceania
- 5.3.5. Latin America
- 5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region

6. North America Interventional Oncology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
- 6.2.1. By Country
- 6.2.2. By Product
- 6.2.3. By Cancer Type
- 6.2.4. By Route of Administration
- 6.2.5. By End User
6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
- 6.3.1. U.S.
- 6.3.2. Canada
6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
- 6.4.1. Radiation Therapy Devices
- 6.4.2. Ablation Devices
  - 6.4.2.1. Microwave ablation
  - 6.4.2.2. Radiofrequency ablation
  - 6.4.2.3. Cryoablation
  - 6.4.2.4. Others
- 6.4.3. Embolization Devices
  - 6.4.3.1. Microcatheters
  - 6.4.3.2. Guidewires
6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2024-2031
- 6.5.1. Lung Cancer
- 6.5.2. Liver Cancer
- 6.5.3. Kidney Cancer
- 6.5.4. Others
6.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
- 6.6.1. Hospitals
- 6.6.2. Specialty Clinics
- 6.6.3. Ambulatory Surgical Center
- 6.6.4. Others
6.7. Market Attractiveness Analysis

7. Europe Interventional Oncology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

7.1. Key Highlights
7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
- 7.2.1. By Country
- 7.2.2. By Product
- 7.2.3. By Cancer Type
- 7.2.4. By Route of Administration
- 7.2.5. By End User
7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
- 7.3.1. Germany
- 7.3.2. France
- 7.3.3. U.K.
- 7.3.4. Italy
- 7.3.5. Spain
- 7.3.6. Russia
- 7.3.7. Turkey
- 7.3.8. Rest of Europe
7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
- 7.4.1. Radiation Therapy Devices
- 7.4.2. Ablation Devices
  - 7.4.2.1. Microwave ablation
  - 7.4.2.2. Radiofrequency ablation
  - 7.4.2.3. Cryoablation
  - 7.4.2.4. Others
- 7.4.3. Embolization Devices
  - 7.4.3.1. Microcatheters
  - 7.4.3.2. Guidewires
7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2024-2031
- 7.5.1. Lung Cancer
- 7.5.2. Liver Cancer
- 7.5.3. Kidney Cancer
- 7.5.4. Others
7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
- 7.6.1. Hospitals
- 7.6.2. Specialty Clinics
- 7.6.3. Ambulatory Surgical Center
- 7.6.4. Others
7.7. Market Attractiveness Analysis

8. East Asia Interventional Oncology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

8.1. Key Highlights
8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
- 8.2.1. By Country
- 8.2.2. By Product
- 8.2.3. By Cancer Type
- 8.2.4. By Route of Administration
- 8.2.5. By End User
8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
- 8.3.1. China
- 8.3.2. Japan
- 8.3.3. South Korea
8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
- 8.4.1. Radiation Therapy Devices
- 8.4.2. Ablation Devices
  - 8.4.2.1. Microwave ablation
  - 8.4.2.2. Radiofrequency ablation
  - 8.4.2.3. Cryoablation
  - 8.4.2.4. Others
- 8.4.3. Embolization Devices
  - 8.4.3.1. Microcatheters
  - 8.4.3.2. Guidewires
8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2024-2031
- 8.5.1. Lung Cancer
- 8.5.2. Liver Cancer
- 8.5.3. Kidney Cancer
- 8.5.4. Others
8.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
- 8.6.1. Hospitals
- 8.6.2. Specialty Clinics
- 8.6.3. Ambulatory Surgical Center
- 8.6.4. Others
8.7. Market Attractiveness Analysis

9. South Asia & Oceania Interventional Oncology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

9.1. Key Highlights
9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
- 9.2.1. By Country
- 9.2.2. By Product
- 9.2.3. By Cancer Type
- 9.2.4. By Route of Administration
- 9.2.5. By End User
9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
- 9.3.1. India
- 9.3.2. Southeast Asia
- 9.3.3. ANZ
- 9.3.4. Rest of South Asia & Oceania
9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
- 9.4.1. Radiation Therapy Devices
- 9.4.2. Ablation Devices
  - 9.4.2.1. Microwave ablation
  - 9.4.2.2. Radiofrequency ablation
  - 9.4.2.3. Cryoablation
  - 9.4.2.4. Others
- 9.4.3. Embolization Devices
  - 9.4.3.1. Microcatheters
  - 9.4.3.2. Guidewires
9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2024-2031
- 9.5.1. Lung Cancer
- 9.5.2. Liver Cancer
- 9.5.3. Kidney Cancer
- 9.5.4. Others
9.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
- 9.6.1. Hospitals
- 9.6.2. Specialty Clinics
- 9.6.3. Ambulatory Surgical Center
- 9.6.4. Others
9.7. Market Attractiveness Analysis

10. Latin America Interventional Oncology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

10.1. Key Highlights
10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
- 10.2.1. By Country
- 10.2.2. By Product
- 10.2.3. By Cancer Type
- 10.2.4. By Route of Administration
- 10.2.5. By End User
10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
- 10.3.1. Brazil
- 10.3.2. Mexico
- 10.3.3. Rest of Latin America
10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
- 10.4.1. Radiation Therapy Devices
- 10.4.2. Ablation Devices
  - 10.4.2.1. Microwave ablation
  - 10.4.2.2. Radiofrequency ablation
  - 10.4.2.3. Cryoablation
  - 10.4.2.4. Others
- 10.4.3. Embolization Devices
  - 10.4.3.1. Microcatheters
  - 10.4.3.2. Guidewires
10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2024-2031
- 10.5.1. Lung Cancer
- 10.5.2. Liver Cancer
- 10.5.3. Kidney Cancer
- 10.5.4. Others
10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
- 10.6.1. Hospitals
- 10.6.2. Specialty Clinics
- 10.6.3. Ambulatory Surgical Center
- 10.6.4. Others
10.7. Market Attractiveness Analysis

11. Middle East & Africa Interventional Oncology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

11.1. Key Highlights
11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
- 11.2.1. By Country
- 11.2.2. By Product
- 11.2.3. By Cancer Type
- 11.2.4. By Route of Administration
- 11.2.5. By End User
11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
- 11.3.1. GCC Countries
- 11.3.2. Egypt
- 11.3.3. South Africa
- 11.3.4. Northern Africa
- 11.3.5. Rest of Middle East & Africa
11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
- 11.4.1. Radiation Therapy Devices
- 11.4.2. Ablation Devices
  - 11.4.2.1. Microwave ablation
  - 11.4.2.2. Radiofrequency ablation
  - 11.4.2.3. Cryoablation
  - 11.4.2.4. Others
- 11.4.3. Embolization Devices
  - 11.4.3.1. Microcatheters
  - 11.4.3.2. Guidewires
11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2024-2031
- 11.5.1. Lung Cancer
- 11.5.2. Liver Cancer
- 11.5.3. Kidney Cancer
- 11.5.4. Others
11.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
- 11.6.1. Hospitals
- 11.6.2. Specialty Clinics
- 11.6.3. Ambulatory Surgical Center
- 11.6.4. Others
11.7. Market Attractiveness Analysis

12. Competition Landscape

12.1. Market Share Analysis, 2023
12.2. Market Structure
- 12.2.1. Competition Intensity Mapping By Market
- 12.2.2. Competition Dashboard
12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 12.3.1. Profound Medical
  - 12.3.1.1. Overview
  - 12.3.1.2. Segments and Products
  - 12.3.1.3. Key Financials
  - 12.3.1.4. Market Developments
  - 12.3.1.5. Market Strategy
- 12.3.2. Medtronic Plc.
- 12.3.3. Hologic, Inc.
- 12.3.4. Boston Scientific Corporation
- 12.3.5. AngioDynamics
- 12.3.6. Terumo Corporation
- 12.3.7. Teleflex Incorporated
- 12.3.8. Alpinion Medical Systems Co. Ltd.
- 12.3.9. Siemens Healthineers
- 12.3.10. Merit Medical

13. Appendix

13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations